You are viewing a Web site, archived on 13:06:47 Oct 20, 2004. It is now a Federal record managed by the National Archives and Records Administration.
External links, forms, and search boxes may not function within this collection.

U.S. Food and Drug Administration Center for Drug Evaluation and Research

Oncologytoolscouple.GIF(7450 bytes)


 (2012 bytes)
Dis_Sum.gif (1491  

 (1693 bytes)
Onc_Ref.gif (2226  
Pat_Liaison.gif (1806 bytes)
add_res.gif (1492  
fda_rev.gif (1619  

 (1445 bytes)

French/Francais   German/Deutsch   Dutch/Nederlands   Japanese   Arabic

Welcome to the FDA Oncology Tools web site!  Oncology Tools contains a variety of information related to cancer and approved cancer drug therapies.  You may take a quick tour of the information here,  select a category from the menu on the left or from the brief descriptions below. View what is new for approvals, upcoming meetings, and on this site.

Rather than grouping all drug product information together, this web page is a first effort at pulling together information by disease category which we hope will make this information easier to find and use.  This is a pilot project, and we encourage you to give us lots of feedback about what you like and don't like about the page and how it can be made more useful to you.  We'll be using your comments to improve this page and to determine whether to expand this approach  to other disease categories.  Comments.
Approved Oncology Drugs - contains information about approved cancer therapies, product labels, approval summaries, what drugs are approved for what diseases, and considerations for making decisions about therapies, including advice on when to contemplate using unapproved drugs and how to obtain access to unapproved drugs.
Disease Summaries - links to sources of information on specific cancers and an oncology dictionary.
Regulatory Tools - covers the FDA approval process, specific FDA cancer initiatives, and other regulatory issues related to cancer.  In addition, it contains a regulatory dictionary, the Oncologic Drugs Advisory Committee (ODAC) meeting calendar , a searchable archive of ODAC meeting transcripts, and FDA guidance documents.
Oncology Reference Tools - assessment tools for staging, performance status, toxicity, and human and animal dosage calculators.
Patient Liaison Program - information from the FDA's Office of Special Health about FDA patient programs and other resources, including a listing of clinical trials (no FDA endorsement is implied).
Additional Resources - links to other regulatory and cancer-related information, including clinical trials (no FDA endorsement is implied), journals, medical centers, the National Cancer Institute, and selected primary source information.
FDA Centers and Divisions - links to the specific FDA centers and divisions that have responsibility for cancer-related products.

We welcome your  Comments regarding this Web site.

Adobe Acrobat  Document Some of these documents are in Portable Document Format (PDF) in order to retain the original format. To view or print these documents, you must use the Adobe Acrobat viewer. Acrobat is free and available directly from Adobe's web site with full installation instructions. Get Adobe Acrobat

FDA/Center for Drug Evaluation and Research
Last Updated: 
Originator: OTCOM/DLIS